TGFB3 and neoplasm: Our results provided evidence that TGN treatment significantly reduced bladder tumorigenic properties, notably tumor spheroid forming ability, cisplatin resistance, and CAF transforming capability; TGN's anticancer function was associated with the downregulation of the TGY signature, supporting our observations where TGFβ3 plays a key role in CAF transformation.